“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy” (2022) Farmeconomia. Health economics and therapeutic pathways, 23(1). doi:10.7175/fe.v23i1.1510.